ScholarBank@NUS
metadata only
IDENTIFYING AND OVERCOMING UNCERTAINTY IN COST-EFFECTIVENESS ANALYSIS OF NEW THERAPEUTIC PRODUCTS FOR MANAGING ACUTE LYMPHOBLASTIC LEUKAEMIA IN SINGAPORE
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment#877824
- LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy#1171408
- BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.#913922
- Bisantrene Combination for Resistant AML#833754
- Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.#382576
Record · ID 288516
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive